- Home
- GSBC vs GKOS Comparison
GSBC vs GKOS Comparison
Compare GSBC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- GKOS
- Stock Information
- Founded
- GSBC 1923
- GKOS 1998
- Country
- GSBC United States
- GKOS United States
- Employees
- GSBC N/A
- GKOS N/A
- Industry
- GSBC Major Banks
- GKOS Medical/Dental Instruments
- Sector
- GSBC Finance
- GKOS Health Care
- Exchange
- GSBC Nasdaq
- GKOS Nasdaq
- Market Cap
- GSBC 676.3M
- GKOS 5.4B
- IPO Year
- GSBC N/A
- GKOS 2015
- Fundamental
- Price
- GSBC $61.97
- GKOS $82.38
- Analyst Decision
- GSBC Hold
- GKOS Strong Buy
- Analyst Count
- GSBC 2
- GKOS 12
- Target Price
- GSBC $60.50
- GKOS $128.58
- AVG Volume (30 Days)
- GSBC 31.5K
- GKOS 698.2K
- Earning Date
- GSBC 10-15-2025
- GKOS 11-03-2025
- Dividend Yield
- GSBC 2.55%
- GKOS N/A
- EPS Growth
- GSBC 17.24
- GKOS N/A
- EPS
- GSBC 5.86
- GKOS N/A
- Revenue
- GSBC $224,299,000.00
- GKOS $432,953,000.00
- Revenue This Year
- GSBC N/A
- GKOS $28.79
- Revenue Next Year
- GSBC N/A
- GKOS $25.65
- P/E Ratio
- GSBC $10.70
- GKOS N/A
- Revenue Growth
- GSBC 4.82
- GKOS 26.70
- 52 Week Low
- GSBC $47.58
- GKOS $77.10
- 52 Week High
- GSBC $68.02
- GKOS $163.71
- Technical
- Relative Strength Index (RSI)
- GSBC 51.77
- GKOS 35.40
- Support Level
- GSBC N/A
- GKOS $80.52
- Resistance Level
- GSBC $63.81
- GKOS $95.32
- Average True Range (ATR)
- GSBC 0.86
- GKOS 2.82
- MACD
- GSBC -2.53
- GKOS -1.23
- Stochastic Oscillator
- GSBC 94.83
- GKOS 11.29
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About GKOS Glaukos Corporation
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.